Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
121
121 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- BR1400-CPhase 21 trial
Boryung Pharmaceutical Co., Ltd · Essential Hypertension
- CTX340Phase 21 trial
CRISPR Therapeutics AG · Hypertension
- DIAG723Phase 21 trial
Diagonal Therapeutics, Inc. · Hereditary Hemorrhagic Telangiectasia, Pulmonary Arterial Hypertension
- HRS-9563Phase 21 trial
Fujian Shengdi Pharmaceutical Co., Ltd. · Mild to Moderate Hypertension
- IBI3016Phase 21 trial
Innovent Biologics (Suzhou) Co. Ltd. · Hypertension
- intraocular implant releasing timololTimoD implantPhase 21 trial
EyeD Pharma · Glaucoma, Ocular Hypertension
- PF-07868489Phase 21 trial
Pfizer · Pulmonary Arterial Hypertension
- PG043Phase 21 trial
Alcon Research · Open Angle Glaucoma, Ocular Hypertension
- REGN13335Phase 21 trial
Regeneron · Pulmonary Arterial Hypertension (PAH)
- REGN22530Phase 21 trial
Regeneron · Primary Open Angle Glaucoma (POAG), Ocular Hypertension (OHT)
- ROC-101Phase 21 trial
AllRock Bio, Inc. · Pulmonary Arterial Hypertension (PAH), Pulmonary Hypertension, Interstitial Lung Disease
- RTN-001SLx-2101Phase 21 trial
Retension Pharmaceuticals. Inc. · Uncontrolled Hypertension
- SPC 2002Phase 21 trial
Shin Poong Pharmaceutical Co. Ltd. · Hypertension, Essential, Cardiovascular Diseases, Cardiology
- SPC 2003Phase 21 trial
Shin Poong Pharmaceutical Co. Ltd. · Hypertension, Essential, Cardiovascular Diseases, Cardiology
- SPC 2004Phase 21 trial
Shin Poong Pharmaceutical Co. Ltd. · Hypertension, Essential, Cardiovascular Diseases, Cardiology
- SPC1001Phase 21 trial
Shin Poong Pharmaceutical Co. Ltd. · Hypertension (HTN), NYHA Class III Heart Failure, NYHA Class IV Heart Failure
- SPC5002Phase 21 trial
Shin Poong Pharmaceutical Co. Ltd. · Hypertension (HTN), NYHA Class III Heart Failure, NYHA Class IV Heart Failure
- SPC5003Phase 21 trial
Shin Poong Pharmaceutical Co. Ltd. · Hypertension (HTN), NYHA Class III Heart Failure, NYHA Class IV Heart Failure
- SPC5004Phase 21 trial
Shin Poong Pharmaceutical Co. Ltd. · Hypertension (HTN), NYHA Class III Heart Failure, NYHA Class IV Heart Failure
- SYH2062Phase 21 trial
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. · Mild to Moderate Primary Hypertension
- VB19055Phase 21 trial
Zhejiang Yangli Pharmaceutical Technology Co., Ltd. · Hypertension, Resistant Hypertension, Uncontrolled Hypertension
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.